References
- Yasui T, Iguchi M, Suzuki S, Kohri K. Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology 2008;71:209–13.
- Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 2003;170:2202–5.
- Troxel SA, Jones AW, Magliola L, Benson JS. Physiologic effect of nifedipine and tamsulosin on contractility of distal ureter. J Endourol 2006;20:565–8.
- Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol 2005;173:2010–2.
- Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K. Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol 2007;14:749–53.
- Porpiglia F, Ghignone G, Fiori C, Fontana D, Scarpa RM. Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 2004;172:568–71.
- Resim S, Ekerbicer H, Ciftci A. Effect of tamsulosin on the number and intensity of ureteral colic in patients with lower ureteral calculus. Int J Urol 2005;12:615–20.
- Avdoshin VP, Andriukhin MI, Barabash MI, Taskinen IuI, Ol'shanskaia EV, Motin PI, Tamsulosin in the treatment of patients with ureteroliths of the lower third of the ureter clinical and pharmacoeconomic grounds. Urologiia 2005;4:36–9.
- Autorino R, De Sio M, Damiano R, Di Lorenzo G, Perdonà S, Russo A, The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand? Urol Res 2005;33:460–4.
- Porpiglia F, Vaccino D, Billia M, Renard J, Cracco C, Ghignone G, Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association? Eur Urol 2006;50:339–44.
- Agrawal M, Gupta M, Gupta A, Agrawal A, Sarkari A, Lavania P. Prospective randomized trial comparing efficacy of alfuzosin and tamsulosin in management of lower ureteral stones. Urology 2009;73:706–9.
- Maksimov VA, Khodyreva LA, Mudraia IS, Moskalenko SA, Martov AG, Stupak NV, Tamsulosin in combined treatment of patients with urolithiasis. Urologiia 2009;4:3–6. (In Russian.)
- Sun X, He L, Ge W, Lv J. Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones. J Urol 2009;181:1716–20.
- Murakami M, Yamaguchi K, Mori I, Naito H, Miyauchi T, Ito H, Clinical statistics on urolithiasis. Nippon Hinyokika Gakkai Zasshi 1982;73:1395–401. (In Japanese.)
- Ishigami J, Ooshima H, Saitou H. Clinical effect of UROCALUN on urolithiasis in the upper urinary tract. Hifu to Hinyo 1967;29:858–62. (In Japanese.)
- Natsukawa T, Hirata K, Noda K, Oka M, Tanaka M, Hamada K, Promoting effect of extract of Quercus salicina Blume/Q. stenophylla Makino (UROCALUN) on urinary stone passage. Jpn Pharmacol Ther 2005;33:361–8. (In Japanese.)
- Ookita K, Yamada S, Johsen T, Tanaka M. Uses of UC-2 for treatment of upper urinary calculi and studies on dissolution of urinary calculi by UC-2. Hifu to Hinyo 1967;30:426–31. (In Japanese.)
- Moriyama MT, Suga K, Miyazawa K, Tanaka T, Higashioka M, Noda K, Inhibitions of urinary oxidative stress and renal calcium level by an extract of Quercus salicina Blume/Quercus stenophylla Makino in a rat calcium oxalate urolithiasis model. Int J Urol 2009;16:397–401.
- Murata S, Ooe H, Mishina T, Mori Y, Tanaka S. Medical Treatment of ureteral stones – clinical evaluation of cospanon. Nishinippon J Urol 1975;37:157–9. (In Japanese.)
- Ichikawa S, Yaegashi T. Effects of 2,4,6-trihydroxypropiophenone on the motility of bile duct and ureter. Jpn J Smooth Muscle Res 1968;4:151–9. (In Japanese.)
- Kawabe K, Tsuchida S, Shimazaki J, Morita T, Yasuda K, Kageyama S. Effect on urapidil on benign prostatic hypertrophy: a multicenter, double-blind study. Urol Int 1993;50:27–32.
- Kawabe K, Ueno A, Takimoto Y, Aso Y, Kato H, YM617 clinical study group. Use of an α1-blocker, YM617, in the treatment of benign prostatic hypertrophy. J Urol 1990;144:908–12.
- Yamaguchi O, Fukaya Y, Shiraiwa Y, Kaneko S, Yachiku S, Honma Y, Dose-dependent effects and clinical usefulness of naftopidil (KT-611) on urinary obstruction caused by benign prostatic hyperplasia–double-blind comparative study compared with placebo. Clin Rep 1997;31:1315–60. (In Japanese.)